List of Tables
    Table 1. Angiotensin Converting Enzyme (ACE) Inhibitors CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Angiotensin Converting Enzyme (ACE) Inhibitors Market Trends
    Table 3. Angiotensin Converting Enzyme (ACE) Inhibitors Market Drivers
    Table 4. Angiotensin Converting Enzyme (ACE) Inhibitors Market Challenges
    Table 5. Angiotensin Converting Enzyme (ACE) Inhibitors Market Restraints
    Table 6. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Manufacturer, (K MT), 2017-2022
    Table 14. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Share by Manufacturer, 2017-2022
    Table 15. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Angiotensin Converting Enzyme (ACE) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Angiotensin Converting Enzyme (ACE) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiotensin Converting Enzyme (ACE) Inhibitors as of 2021)
    Table 18. Top Players of Angiotensin Converting Enzyme (ACE) Inhibitors in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Angiotensin Converting Enzyme (ACE) Inhibitors Product Type
    Table 20. Date of International Manufacturers Enter into Angiotensin Converting Enzyme (ACE) Inhibitors Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Angiotensin Converting Enzyme (ACE) Inhibitors Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Angiotensin Converting Enzyme (ACE) Inhibitors Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Players, (K MT), 2020, 2021 & 2022
    Table 26. United States Angiotensin Converting Enzyme (ACE) Inhibitors Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Region (2017-2022) & (K MT)
    Table 29. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume Forecast by Region (2023-2028) & (K MT)
    Table 30. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Country (2017-2028) & (K MT)
    Table 33. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Region (2017-2028) & (K MT)
    Table 35. Asia Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Country (2017-2028) & (K MT)
    Table 37. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Country (2017-2028) & (K MT)
    Table 39. Latin Americaa Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume by Country (2017-2028) & (K MT)
    Table 41. Middle East and Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Abbott Laboratories Corporation Information
    Table 43. Abbott Laboratories Description and Business Overview
    Table 44. Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Abbott Laboratories Angiotensin Converting Enzyme (ACE) Inhibitors Product
    Table 46. Abbott Laboratories Recent Development
    Table 47. Pfizer Corporation Information
    Table 48. Pfizer Description and Business Overview
    Table 49. Pfizer Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Pfizer Product
    Table 51. Pfizer Recent Development
    Table 52. Novartis Corporation Information
    Table 53. Novartis Description and Business Overview
    Table 54. Novartis Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Novartis Product
    Table 56. Novartis Recent Development
    Table 57. Merck Corporation Information
    Table 58. Merck Description and Business Overview
    Table 59. Merck Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Merck Product
    Table 61. Merck Recent Development
    Table 62. Astra Zeneca Corporation Information
    Table 63. Astra Zeneca Description and Business Overview
    Table 64. Astra Zeneca Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Astra Zeneca Product
    Table 66. Astra Zeneca Recent Development
    Table 67. Jhonson and Johnson Corporation Information
    Table 68. Jhonson and Johnson Description and Business Overview
    Table 69. Jhonson and Johnson Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Jhonson and Johnson Product
    Table 71. Jhonson and Johnson Recent Development
    Table 72. Eli Lilly Corporation Information
    Table 73. Eli Lilly Description and Business Overview
    Table 74. Eli Lilly Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Eli Lilly Product
    Table 76. Eli Lilly Recent Development
    Table 77. Sanofi Corporation Information
    Table 78. Sanofi Description and Business Overview
    Table 79. Sanofi Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Sanofi Product
    Table 81. Sanofi Recent Development
    Table 82. Bristol-Myers Squibb Corporation Information
    Table 83. Bristol-Myers Squibb Description and Business Overview
    Table 84. Bristol-Myers Squibb Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Bristol-Myers Squibb Product
    Table 86. Bristol-Myers Squibb Recent Development
    Table 87. Bayer Corporation Information
    Table 88. Bayer Description and Business Overview
    Table 89. Bayer Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Bayer Product
    Table 91. Bayer Recent Development
    Table 92. GSK Corporation Information
    Table 93. GSK Description and Business Overview
    Table 94. GSK Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. GSK Product
    Table 96. GSK Recent Development
    Table 97. Teva Pharmaceutical Corporation Information
    Table 98. Teva Pharmaceutical Description and Business Overview
    Table 99. Teva Pharmaceutical Angiotensin Converting Enzyme (ACE) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 100. Teva Pharmaceutical Product
    Table 101. Teva Pharmaceutical Recent Development
    Table 102. Key Raw Materials Lists
    Table 103. Raw Materials Key Suppliers Lists
    Table 104. Angiotensin Converting Enzyme (ACE) Inhibitors Customers List
    Table 105. Angiotensin Converting Enzyme (ACE) Inhibitors Distributors List
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Angiotensin Converting Enzyme (ACE) Inhibitors Product Picture
    Figure 2. Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Size 2017-2028 (US$ Million)
    Figure 4. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales 2017-2028 (K MT)
    Figure 5. United States Angiotensin Converting Enzyme (ACE) Inhibitors Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Angiotensin Converting Enzyme (ACE) Inhibitors Market Size 2017-2028 (US$ Million)
    Figure 7. United States Angiotensin Converting Enzyme (ACE) Inhibitors Sales 2017-2028 (K MT)
    Figure 8. United States Angiotensin Converting Enzyme (ACE) Inhibitors Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Angiotensin Converting Enzyme (ACE) Inhibitors Market Share in Global, in Volume (K MT) 2017-2028
    Figure 10. Angiotensin Converting Enzyme (ACE) Inhibitors Report Years Considered
    Figure 11. Product Picture of Sulfhydryl-containing Agents
    Figure 12. Product Picture of Dicarboxylate-containing Agents
    Figure 13. Product Picture of Phosphonate-containing Agents
    Figure 14. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Share by Type in 2022 & 2028
    Figure 15. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2017-2028) & (K MT)
    Figure 18. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Type (2017-2028) & (USD/Unit)
    Figure 20. United States Angiotensin Converting Enzyme (ACE) Inhibitors Market Share by Type in 2022 & 2028
    Figure 21. United States Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Type (2017-2028) & (K MT)
    Figure 24. United States Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Angiotensin Converting Enzyme (ACE) Inhibitors Price by Type (2017-2028) & (USD/Unit)
    Figure 26. Product Picture of Hypertension
    Figure 27. Product Picture of Cardiovascular Diseases
    Figure 28. Product Picture of Kidney Diseases
    Figure 29. Product Picture of Other
    Figure 30. Global Angiotensin Converting Enzyme (ACE) Inhibitors Market Share by Application in 2022 & 2028
    Figure 31. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2017-2028) & (K MT)
    Figure 34. Global Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global Angiotensin Converting Enzyme (ACE) Inhibitors Price by Application (2017-2028) & (USD/Unit)
    Figure 36. United States Angiotensin Converting Enzyme (ACE) Inhibitors Market Share by Application in 2022 & 2028
    Figure 37. United States Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States Angiotensin Converting Enzyme (ACE) Inhibitors Sales by Application (2017-2028) & (K MT)
    Figure 40. United States Angiotensin Converting Enzyme (ACE) Inhibitors Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States Angiotensin Converting Enzyme (ACE) Inhibitors Price by Application (2017-2028) & (USD/Unit)
    Figure 42. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 43. North America Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. U.S. Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 47. Europe Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. Germany Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. France Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. U.K. Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Italy Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Russia Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 54. Asia-Pacific Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 55. China Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Japan Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. South Korea Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. India Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Australia Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Taiwan Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Philippines Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 66. Latin America Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 67. Mexico Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Brazil Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Argentina Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 71. Middle East & Africa Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Turkey Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Saudi Arabia Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. U.A.E Angiotensin Converting Enzyme (ACE) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Angiotensin Converting Enzyme (ACE) Inhibitors Value Chain
    Figure 76. Angiotensin Converting Enzyme (ACE) Inhibitors Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed